Role of bacterial and genetic factors in gastric cancer in Costa Rica

World Journal of Gastroenterology

Volumn 15, Issue 2, 2009, Pages 211-218

  Con, Sergio A ^a,b   Takeuchi, Hiroaki ^b   Con Chin, Gil R ^a   Con Chin, Vicky G ^a   Yasuda, Nobufumi ^b   Con Wong, Reinaldo ^a  

^a Centro Digestivo Doctores Con Mediplaza   (Costa Rica)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Costa Rica; Gastric cancer; Helicobacter pylori; Host genetic factors

Indexed keywords

BABA2 PROTEIN; CAGA PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 1RN; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VIRULENCE FACTOR;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; COSTA RICA; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH BIOPSY; STOMACH CANCER; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 59249101028     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.211     Document Type: Article

References (35)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 Suppl 8: S4-S66
2. Kuroishi T, Hirose K, Takesaki T, Tomminaga S, Aoki K, Tajima K. Cancer mortality statistics in 30 countries (1953-1997). In: Tajima K, Kuroishi T, Oshima A, eds. Cancer Mortality and Morbidity Statistics: Japan and the World-2004. Tokyo: Japan Scientific Societies Press, 2004: 165-229
3. Miranda M, Macaya J, Moya de Madrigal L. Aspectos epidemiológicos del cáncer gástrico en Costa Rica (in Spanish). Acta Med Costarric 1997; 20: 207-214
4. Mora D. Evolución de algunos aspectos epidemiológicos y ecológicos del cáncer gástrico en Costa Rica (in Spanish). Rev Costarric Salud Publica 2003; 21: 7-17
5. Sierra R, Barrantes R. [Ecological aspects of gastric cancer in Costa Rica] Rev Biol Trop 1983; 31: 11-18
6. Aird I, Bentall HH, Roberts JA. A relationship between cancer of stomach and the ABO blood groups. Br Med J 1953; 1: 799-801
7. Glober GA, Cantrell EG, Doll R, Peto R. Interaction between ABO and rhesus blood groups, the site of origin of gastric cancers, and the age and sex of the patient. Gut 1971; 12: 570-573
8. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999; 94: 2373-2379
9. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114: 1169-1179
10. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353
11. Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999; 13: 851-856
12. Basso D, Navaglia F, Brigato L, Piva MG, Toma A, Greco E, Di Mario F, Galeotti F, Roveroni G, Corsini A, Plebani M. Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases. Gut 1998; 43: 182-186
13. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999; 37: 2274-2279
14. Zambon CF, Navaglia F, Basso D, Rugge M, Plebani M. Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol 2003; 56: 287-291
15. Zambon CF, Basso D, Navaglia F, Germano G, Gallo N, Milazzo M, Greco E, Fogar P, Mazza S, Di Mario F, Basso G, Rugge M, Plebani M. Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine 2002; 18: 242-251
16. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, Yamaoka Y. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002; 123: 1793-1803
17. Peek RM Jr, Blaser MJ. Helicobacterpylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2: 28-37
18. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402
19. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doorn LJ, Carneiro F, Sobrinho-Simoes M. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify highrisk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94: 1680-1687
20. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, Castro Alves C, Campos ML, Van Doorn LJ, Caldas C, Seruca R, Carneiro F, Sobrinho-Simoes M. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125: 364-371
21. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF Jr, Chow WH. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-1201
22. Akopyanz N, Bukanov NO, Westblom TU, Kresovich S, Berg DE. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res 1992; 20: 5137-5142
23. Marshall DG, Coleman DC, Sullivan DJ, Xia H, O'Morain CA, Smyth CJ. Genomic DNA fingerprinting of clinical isolates of Helicobacter pylori using short oligonucleotide probes containing repetitive sequences. J Appl Bacteriol 1996; 81: 509-517
24. Con SA, Valeren AL, Takeuchi H, Con-Wong R, Con-Chin VG, Con-Chin GR, Yagi-Chaves SN, Mena F, Brenes Pino F, Echandi G, Kobayashi M, Monge-Izaguirre M, Nishioka M, Morimoto N, Sugiura T, Araki K. Helicobacter pylori CagA status associated with gastric cancer incidence rate variability in Costa Rican regions. J Gastroenterol 2006; 41: 632-637
25. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
26. Shih CM, Lee YL, Chiou HL, Hsu WF, Chen WE, Chou MC, Lin LY. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung Cancer 2005; 50: 291-297
27. Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, Ng M, Sung JJ. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 2003; 52: 1684-1689
28. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5795
29. Con SA, Takeuchi H, Valerin AL, Con-Wong R, Con-Chin GR, Con-Chin VG, Nishioka M, Mena F, Brenes F, Yasuda N, Araki K, Sugiura T. Diversity of Helicobacter pylori cagA and vacA genes in Costa Rica: its relationship with atrophic gastritis and gastric cancer. Helicobacter 2007; 12: 547-552
30. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-17777
31. Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 1999; 96: 12778-12783
32. Ashour AA, Magalhaes PP, Mendes EN, Collares GB, de Gusmao VR, Queiroz DM, Nogueira AM, Rocha GA, de Oliveira CA. Distribution of vacA genotypes in Helicobacter pylori strains isolated from Brazilian adult patients with gastritis, duodenal ulcer or gastric carcinoma. FEMS Immunol Med Microbiol 2002; 33: 173-178
33. Con SA, Con-Wong R, Con-Chin GR, Con-Chin VG, Takeuchi H, Valeren AL, Echandi G, Mena F, Brenes F, Yasuda N, Araki K, Sugiura T. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica. Cancer Epidemiol Biomarkers Prev 2007; 16: 2631-2636
34. Alpizar-Alpizar W, Perez-Perez GI, Une C, Cuenca P, Sierra R. Association of interleukin-1B and interleukin1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin Exp Med 2005; 5: 169-176
35. Kauser F, Khan AA, Hussain MA, Carroll IM, Ahmad N, Tiwari S, Shouche Y, Das B, Alam M, Ali SM, Habibullah CM, Sierra R, Megraud F, Sechi LA, Ahmed N. The cag pathogenicity island of Helicobacter pylori is disrupted in the majority of patient isolates from different human populations. J Clin Microbiol 2004; 42: 5302-5308